Skip to main content

Table 1 Characteristics of the participants

From: Development and validation of a new Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) with focus on symptom burden

 

Radiofrequency catheter ablation - RFA

Emergency care

Diagnoses and patients

TotalN = 270

AVNRT n = 40

WPWn = 16

FATn=8

Atrial macro-reentryn = 4

AFLn = 16

AFn = 126

Ventricul ararrhythmian = 5

AFn = 55

Age mean (SD)

59.3(12.9)

54.6(13.1)

38.8(15.4)

54.3(17.5)

59.3(10.0)

59.1(15.3)

60.3(9.3)

60.6(13.0)

67.3(10.3)

GenderF/M(M %)

93/177(66)

23/17(43)

8/8(50)

5/3(38)

1/3(75)

3/13(81)

33/93(74)

0/5(100)

20/35(64)

Cohabitant/living alone(cohabit. %) 1

223/45(83)

35/5(88)

13/3(81)

7/1(88)

3/1(75)

14/2(88)

105/20(83)

4/1(8)

42/12(76)

Education 2

Elementary school certificate

26(10)

3(7.5)

1(6)

0

1(25)

0

10(8)

0

11(20)

Compulsory school certificate

71(26)

14(35)

2(13)

4(50)

0

2(13)

34(27)

0

15(27)

Upper secondary school certificate

96(36)

11(28)

9(56)

3(38)

3(75)

7(44)

44(35)

2(40)

17(31)

College/University degree

73(27)

11(28)

4(25)

1(13)

0

7(44)

36(29)

3(60)

11(20)

Medication 3

Class I(%)

46(17)

0

1(6)

0

0

0

38(30)

0

7(13)

Class II(%)

159(59)

16(40)

6(38)

3(38)

2(50)

10(63)

81(64)

2(40)

39(71)

Class III(%)

41(15)

4(10)

0

2(25)

2(50)

1(6)

27(21)

2(40)

3(6)

Class IV(%)

36(13)

1(3)

0

0

2(50)

0

24(19)

0

9(16)

Digitalis(%)

20(7)

0

1(6)

1(13)

0

1(6)

10(8)

1(20)

6(11)

  1. AVNRT = AV-Nodal reentry tachycardia, WPW = Wolff-Parkinson-White syndrome, FAT = focal atrial tachycardia, atrial macro-reentry, AFL atrial flutter, AF = atrial fibrillation, AF patients with out-patient visits in emergency room. Ventricular arrhythmia includes ventricular tachycardia and VES = Ventricular extra beats. RFA = radiofrequency ablation.
  2. 1 2 missing values.
  3. 2 4 missing values.
  4. 3 Here, medication is anti-arrhythmic medication where one patient can have more than one drug.
  5. Class I represents flecainide/propafenon, class II beta blockers, class III amiodarone/sotalol, and class IV calcium channel blockers.